[Clinical value of OK-432 immunotherapy after one-shot arterial infusion of anti-cancer agents in the treatment of hepatocellular carcinoma--a randomized study]

Gan To Kagaku Ryoho. 1988 Mar;15(3):545-7.
[Article in Japanese]
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Administration, Oral
  • Biological Products / therapeutic use*
  • Carcinoma, Hepatocellular / mortality
  • Carcinoma, Hepatocellular / therapy*
  • Clinical Trials as Topic
  • Humans
  • Infusions, Intra-Arterial
  • Liver Neoplasms / mortality
  • Liver Neoplasms / therapy*
  • Mitomycin
  • Mitomycins / administration & dosage*
  • Picibanil / therapeutic use*
  • Random Allocation
  • Tegafur / administration & dosage

Substances

  • Biological Products
  • Mitomycins
  • Tegafur
  • Picibanil
  • Mitomycin